Surgery for adrenocortical carcinoma in the Netherlands: Analysis of the national cancer registry data

European Journal of Endocrinology

Volumn 169, Issue 1, 2013, Pages 83-89

  Kerkhofs, T M A ^a   Verhoeven R h a , ^b   Bonjer, H J ^c   Nieveen Van Dijkum, E J ^d   Vriens, M R ^e   De Vries, J ^f   Van Eijck, C H ^g   Bonsing, B A ^h   Van De Poll Franse, L V ^a,i  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ TILBURG UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84879964268     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0142     Document Type: Article

References (31)

1. Libe R, Fratticci A & Bertherat J. Adrenocortical cancer: pathophysiology and clinicalmanagement. Endocrine-Related Cancer 2007 14 13-28. (doi:10.1677/erc.1.01130)
2. Allolio B & Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update. Journal of Clinical Endocrinology and Metabolism 2006 91 2027-2037. (doi:10.1210/jc.2005-2639)
3. Kebebew E, Reiff E, Duh QY, Clark OH & McMillan A. Extent of Disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World Journal of Surgery 2006 30 872-878. (doi:10.1007/s00268-005-0329-x)
4. Fassnacht M, Johanssen S, Fenske W, Weismann D, Agha A, Beuschlein F, Fuhrer D, Jurowich C, Quinkler M, Petersenn S et al. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. Journal of Clinical Endocrinology and Metabolism 2010 95 4925-4932. (doi:10.1210/jc.2010-0803)
5. Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S & Allolio B. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer 2009 115 243-250. (doi:10.1002/cncr.24030)
6. Malandrino P, Al Ghuzlan A, Castaing M, Young J, Caillou B, Travagli JP, Elias D, de Baere T, Dromain C, Paci A et al. Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma. Endocrine- Related Cancer 2010 17 797-807. (doi:10.1677/ERC-09-0341)
7. Fassnacht M & Allolio B. Clinical management of adrenocortical carcinoma. Best Practice & Research. Clinical Endocrinology & Metabolism 2009 23 273-289. (doi:10.1016/j.beem.2008.10.008)
8. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M & Worden FP. Management of patients with adrenal cancer: recommendations of an International Consensus Conference. Endocrine-Related Cancer 2005 12 667-680. (doi:10.1677/ erc.1.01029)
9. Gooiker GA, van Gijn W, Wouters MW, Post PN, van de Velde CJ, Tollenaar RA & Signalling Committee Cancer of the Dutch Cancer Society. Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. British Journal of Surgery 2011 98 485-494. (doi:10.1002/bjs.7413)
10. Wouters MW, Gooiker GA, van Sandick JW & Tollenaar RA. The volume-outcome relation in the surgical treatment of esophageal cancer: a systematic review and meta-analysis. Cancer 2012 118 1754-1763. (doi:10.1002/cncr.26383)
11. Bilimoria KY, Phillips JD, Rock CE, Hayman A, Prystowsky JB & Bentrem DJ. Effect of surgeon training, specialization, and experience on outcomes for cancer surgery: a systematic review of the literature. Annals of Surgical Oncology 2009 16 1799-1808. (doi:10.1245/s10434-009-0467-8)
12. Chowdhury MM, Dagash H & Pierro A. A systematic review of the impact of volume of surgery and specialization on patient outcome. British Journal of Surgery 2007 94 145-161. (doi:10. 1002/bjs.5714)
13. Villar JM, Moreno P, Ortega J, Bollo E, Ramirez CP, Munoz N, Martinez C, Dominguez-Adame E, Sancho J, del Pino JM et al. Results of adrenal surgery. Data of a Spanish National Survey. Langenbeck's Archives of Surgery 2010 395 837-843. (doi:10.1007/ s00423-010-0697-z)
14. Park HS, Roman SA & Sosa JA. Outcomes from 3144 adrenalectomies in the United States: which matters more, surgeon volume or specialty? Archives of Surgery 2009 144 1060-1067. (doi:10.1001/archsurg.2009.191)
15. Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E et al. Adjuvant mitotane treatment for adrenocortical carcinoma. New England Journal of Medicine 2007 356 2372-2380. (doi:10.1056/ NEJMoa063360)
16. BerrutiA, Fassnacht M, Baudin E,HammerG,HaakH, Leboulleux S, Skogseid B, Allolio B & Terzolo M. Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel. Journal of Clinical Oncology 2010 28 e401-e402 (author reply e403). (doi:10.1200/JCO.2009.27.5958)
17. Fassnacht M, Libe R, Kroiss M & Allolio B. Adrenocortical carcinoma: a clinician's update. Nature Reviews. Endocrinology 2011 7 323-335. (doi:10.1038/nrendo.2010.235)
18. Tacon LJ, Prichard RS, Soon PS, Robinson BG, Clifton-Bligh RJ & Sidhu SB. Current and emerging therapies for advanced adrenocortical carcinoma. Oncologist 2011 16 36-48. (doi:10.1634/ theoncologist.2010-0270)
19. Johanssen S, Hahner S, Saeger W, Quinkler M, Beuschlein F, Dralle H, Haaf M, Kroiss M, Jurowich C, Langer P et al. Deficits in the management of patients with adrenocortical carcinoma in Germany. Deutsches Ärzteblatt International 2010 107 885-891.
20. Hermsen IG, Kerkhofs TM, Butter G, Kievit J, van Eijck CH, Nieveen van Dijkum EJ, Haak HR & Dutch Adrenal Network . Surgery in adrenocortical carcinoma: importance of national cooperation and centralized surgery. Surgery 2012 152 50-56. (doi:10.1016/j.surg.2012.02.005)
21. Fritz AG. International Classification of Diseases for Oncology: ICD-O, 3rd edn, pp 240. Geneva: World Health Organization, 2000.
22. Dehner LP & Hill DA. Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors? Pediatric and Developmental Pathology 2009 12 284-291. (doi:10.2350/08- 06-0489.1)
23. Faria AM & Almeida MQ. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults. Molecular and Cellular Endocrinology 2012 351 52-57. (doi:10.1016/j.mce.2011.09.040)
24. Guinee VF. The International Cancer Patient Data Exchange System (ICPDES). Health Reports/Statistics Canada 1993 5 97-103.
25. Lughezzani G, Sun M, Perrotte P, Jeldres C, Alasker A, Isbarn H, Budaus L, Shariat SF, Guazzoni G, Montorsi F et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the International Union against cancerstaging system: a North American validation. European Journal of Cancer 2010 46 713-719. (doi:10.1016/j.ejca.2009.12.007)
26. Grubbs EG, Callender GG, Xing Y, Perrier ND, Evans DB, Phan AT & Lee JE. Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. Annals of Surgical Oncology 2010 17 263-270. (doi:10.1245/s10434-009-0716-x)
27. Berruti A, Baudin E, Gelderblom H, Haak HR, Porpiglia F, Fassnacht M, Pentheroudakis G & on behalf of the ESMO GuidelinesWorking Group. Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2012 23 vii131-vii138. (doi:10.1093/annonc/mds231)
28. van de Poll-Franse LV, Lemmens VE, Roukema JA, Coebergh JW & Nieuwenhuijzen GA. Impact of concentration of oesophageal and gastric cardia cancer surgery on long-term populationbased survival. British Journal of Surgery 2011 98 956-963. (doi:10.1002/bjs.7493)
29. Lemmens VE, Bosscha K, van der Schelling G, Brenninkmeijer S, Coebergh JW & de Hingh IH. Improving outcome for patients with pancreatic cancer through centralization. British Journal of Surgery 2011 98 1455-1462. (doi:10.1002/bjs.7581)
30. de Wilde RF, Besselink MG, van der Tweel I, de Hingh IH, van Eijck CH, Dejong CH, Porte RJ, Gouma DJ, Busch OR, Molenaar IQ et al. Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality. British Journal of Surgery 2012 99 404-410. (doi:10.1002/bjs.8664)
31. Ho V, de Raaf A, van der Hoeven K & Jansen-Landheer M. IKNL berekent effect volumenormen op ziekenhuizen en patiënten. Medisch Contact 2013 issue 1 34-37.